ifosfamide has been researched along with Seizures in 4 studies
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Generalized and partial seizures with secondary generalization were observed during ifosfamide-mesna (IFO) treatment in a patient with lung epidermoid carcinoma." | 7.69 | [Epileptic seizures and treatment with ifosfamide-mesna]. ( Farisse, P; Somma-Mauvais, H; Viallat, JR, 1994) |
| "Ifosfamide is an alkylating agent used in the treatment of germ-cell tumors, sarcomas and lymphomas." | 3.73 | [Ifosfamide induced encephalopathy: 15 observations]. ( Behar, C; Dufour, C; Grill, J; Hartmann, O; Motte, J; Munzer, M; Oberlin, O; Paci, A; Sabouraud, P, 2006) |
| "Generalized and partial seizures with secondary generalization were observed during ifosfamide-mesna (IFO) treatment in a patient with lung epidermoid carcinoma." | 3.69 | [Epileptic seizures and treatment with ifosfamide-mesna]. ( Farisse, P; Somma-Mauvais, H; Viallat, JR, 1994) |
| "The patients were assigned to dosage cohorts separated on the basis of prior exposure to cisplatin (n = 10) or the absence of such exposure (n = 10)." | 2.67 | A phase I study of ifosfamide given on alternate days to treat children with brain tumors. ( Avery, L; Douglass, EC; Heideman, R; Kellie, SJ; Kovnar, EH; Kun, L; Pratt, CB, 1993) |
| "Ifosfamide/mesna treatment of 50 patients with pediatric malignant solid tumors was associated with the development of neurotoxic signs and symptoms in 11 of these individuals who received 29 courses of treatment." | 1.27 | Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. ( Douglass, E; Etcubanas, E; Green, AA; Hayes, FA; Horowitz, ME; Igarashi, M; Meyer, WH; Pratt, CB; Thompson, E; Wilimas, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dufour, C | 1 |
| Grill, J | 1 |
| Sabouraud, P | 1 |
| Behar, C | 1 |
| Munzer, M | 1 |
| Motte, J | 1 |
| Oberlin, O | 1 |
| Paci, A | 1 |
| Hartmann, O | 1 |
| Somma-Mauvais, H | 1 |
| Farisse, P | 1 |
| Viallat, JR | 1 |
| Pratt, CB | 2 |
| Douglass, EC | 1 |
| Kovnar, EH | 1 |
| Heideman, R | 1 |
| Kun, L | 1 |
| Avery, L | 1 |
| Kellie, SJ | 1 |
| Green, AA | 1 |
| Horowitz, ME | 1 |
| Meyer, WH | 1 |
| Etcubanas, E | 1 |
| Douglass, E | 1 |
| Hayes, FA | 1 |
| Thompson, E | 1 |
| Wilimas, J | 1 |
| Igarashi, M | 1 |
1 trial available for ifosfamide and Seizures
| Article | Year |
|---|---|
A phase I study of ifosfamide given on alternate days to treat children with brain tumors.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Femal | 1993 |
3 other studies available for ifosfamide and Seizures
| Article | Year |
|---|---|
[Ifosfamide induced encephalopathy: 15 observations].
Topics: Adolescent; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Coma; Enzyme Inhibitors; Fat | 2006 |
[Epileptic seizures and treatment with ifosfamide-mesna].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Epilepsy; Fatal Outcome; H | 1994 |
Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; | 1986 |